[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642666":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":53,"centralContacts":57,"locations":63,"responsibleParty":75,"collaborators":36,"id":77,"slug":78,"hasResults":79,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":36,"eligibilityCriteria":83,"healthyVolunteers":79,"sex":84,"minAge":85,"maxAge":36,"enrollmentInfo":86,"targetDuration":36,"studyType":89,"phases":90,"briefSummary":92,"conditions":93,"keywords":36,"overallStatus":95,"whyStopped":36,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"NYU Langone Health","OTHER",[8,15,20,25],{"label":9,"type":10,"description":11,"interventionNames":12},"Bupivacaine + lidocaine","EXPERIMENTAL","Surgical created wounds for any hand surgery will be treated with bupivacaine + lidocaine.",[13,14],"Drug: Bupivacaine","Drug: Lidocaine",{"label":16,"type":10,"description":17,"interventionNames":18},"Bupivacaine + lidocaine + thrombin","Surgical created wounds for any hand surgery will be treated with bupivacaine + lidocaine + thrombin.",[13,14,19],"Drug: Thrombin",{"label":21,"type":10,"description":22,"interventionNames":23},"Bupivacaine + lidocaine + thrombin + tranexamic acid","Surgical created wounds for any hand surgery will be treated with bupivacaine + lidocaine + thrombin + tranexamic acid.",[13,14,19,24],"Drug: Tranexamic acid",{"label":26,"type":10,"description":27,"interventionNames":28},"Bupivacaine + lidocaine + thrombin + aminocaproic acid","Surgical created wounds for any hand surgery will be treated with bupivacaine + lidocaine + thrombin + aminocaproic acid.",[13,14,19,29],"Drug: Aminocaproic acid",[31,37,41,45,49],{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"DRUG","Bupivacaine","5 ml of 0.25% bupivacaine",[9,16,26,21],null,{"type":32,"name":38,"description":39,"armGroupLabels":40,"otherNames":36},"Lidocaine","5 ml of 1% lidocaine",[9,16,26,21],{"type":32,"name":42,"description":43,"armGroupLabels":44,"otherNames":36},"Thrombin","10000 units of thrombin",[16,26,21],{"type":32,"name":46,"description":47,"armGroupLabels":48,"otherNames":36},"Tranexamic acid","500 mg of tranexamic acid",[21],{"type":32,"name":50,"description":51,"armGroupLabels":52,"otherNames":36},"Aminocaproic acid","1000 mg of aminocaproic acid",[26],[54],{"name":55,"affiliation":5,"role":56},"David Chiu, MD","PRINCIPAL_INVESTIGATOR",[58],{"name":59,"role":60,"phone":61,"phoneExt":36,"email":62},"Tom Calahan","CONTACT","929-455-5826","Thomas.Calahan@nyulangone.org",[64],{"facility":5,"status":36,"city":65,"state":65,"zip":66,"country":67,"countryCode":68,"cosmosGeoPoint":69,"geoPoint":74,"contacts":36},"New York","10016","United States","US",{"type":70,"coordinates":71},"Point",[72,73],-74.00597,40.71427,{"lat":73,"lon":72},{"type":76,"investigatorFullName":36,"investigatorTitle":36,"investigatorAffiliation":36,"oldNameTitle":36,"oldOrganization":36},"SPONSOR","100642666","phase-4-postoperative-non-opioid-pain-management-utilizing-local-anesthetics-coupled-with-modulated-coagulation-100642666",false,"NCT07644923","Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation","A Randomized, Single-Blinded, Controlled Study Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation","Inclusion Criteria:\n\n* Age 18 or older\n* Any patient undergoing elective hand surgery\n\nExclusion Criteria:\n\n* Any patient with a traumatic or infected open wound (only surgically created wounds will be included)\n* History of chronic pain\n* History of narcotic addiction\n* History of recreational drug dependency\n* History of psychiatric pathology\n* Allergy or hypersensitivity to local anesthetics, recombinant human thrombin or tranexamic acid\n* History of coagulopathy or active thromboembolic disease\n* Any patient receiving a supra\u002Finfraclavicular block for anesthesia\n* Pregnancy\n* Hypersensitivity to hamster proteins\n* History of seizures\n* Significant renal impairment (chronic kidney disease stage 3 or greater)\n* History of retinal vascular disease or history of unexplained visual symptoms\n* Active upper urinary tract bleeding\n* History of known hypercoagulable disorder, prior thromboembolic events, or active clotting disorders\n* History of severe hepatic dysfunction (active hepatitis or steatohepatitis, hepatic fibrosis considered cirrhosis)","ALL","18 Years",{"count":87,"type":88},40,"ESTIMATED","INTERVENTIONAL",[91],"PHASE4","This study is a prospective randomized trial examining the effect of tranexamic acid (TXA) and aminocaproic acid (ε-Ahx) with local anesthetics and thrombin in all electively created surgical wound beds in hand surgery to provide long term pain relief and decrease the use of postoperative narcotics.\n\nAll surgical created wounds for any hand surgery will be treated in a randomized fashion with the following four arms:\n\n1. Bupivacaine + lidocaine\n2. Bupivacaine + lidocaine + thrombin\n3. Bupivacaine + lidocaine + thrombin + tranexamic acid\n4. Bupivacaine + lidocaine + thrombin + aminocaproic acid\n\nAll are applied topically to surgical bed prior to closure of skin.",[94],"Postoperative Pain","NOT_YET_RECRUITING","2026-06-09",{"date":98,"type":99},"2026-06-12","ACTUAL",{"date":101,"type":88},"2026-08-01",{"date":103,"type":88},"2029-02-01",{"name":5,"class":6},1]